The cost of drug discovery has always been time. Nvidia Corp (NASDAQ:NVDA) says it just crushed that cost by 70% — and Eli Lilly And Co (NYSE:LLY) just put $1 billion behind the claim.At JPMorgan's healthcare conference, Nvidia wasn't pitching AI as a helper in the lab. It was pitching AI as a replacement for the slowest, costliest part of drug discovery: human-paced iteration. Remove that bottleneck, Nvidia argues, and costs don't inch lower — they collapse, by as much as 70%.The Cost Was Never The Science ...

Key TakeawaysNvidia (NVDA) and Eli Lilly (LLY) are jointly investing up to $1 billion over five years to establish an AI co-innovation lab focused on reinventing drug discovery, with operations slated to begin in South San Francisco early this year.Mexican President Claudia Sheinbaum firmly rejected the notion of U.S. military intervention in Mexico, reiterating her stance against foreign military presence and emphasizing national sovereignty, despite former U.S. President Donald Trump's repeated suggestion ...